Journal of Interventional Cardiac Electrophysiology最新文献

筛选
英文 中文
Ultrasound-guided femoral venipuncture for catheter ablation of atrial fibrillation 超声引导股静脉穿刺用于心房颤动的导管消融术
IF 1.8 4区 医学
Journal of Interventional Cardiac Electrophysiology Pub Date : 2024-09-11 DOI: 10.1007/s10840-024-01918-4
Jana Hašková, Josef Kautzner, Petr Peichl, Predrag Stojadinovič, Bashar Aldhoon, Peter Štiavnický, Eva Borišincová, Jiří Plášek, Robert Čihák, Dan Wichterle
{"title":"Ultrasound-guided femoral venipuncture for catheter ablation of atrial fibrillation","authors":"Jana Hašková, Josef Kautzner, Petr Peichl, Predrag Stojadinovič, Bashar Aldhoon, Peter Štiavnický, Eva Borišincová, Jiří Plášek, Robert Čihák, Dan Wichterle","doi":"10.1007/s10840-024-01918-4","DOIUrl":"https://doi.org/10.1007/s10840-024-01918-4","url":null,"abstract":"","PeriodicalId":16202,"journal":{"name":"Journal of Interventional Cardiac Electrophysiology","volume":"1 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142226441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catheter ablation for atrial fibrillation in patients with prior left atrial appendage occlusion device 曾使用左房阑尾闭塞器的患者心房颤动的导管消融术
IF 1.8 4区 医学
Journal of Interventional Cardiac Electrophysiology Pub Date : 2024-09-11 DOI: 10.1007/s10840-024-01914-8
Jakrin Kewcharoen, Kuldeep Shah, Rahul Bhardwaj, Tahmeed Contractor, Davendra Ramsingh, Mohit K. Turagam, Ravi Mandapati, Dhanunjaya Lakkireddy, Jalaj Garg
{"title":"Catheter ablation for atrial fibrillation in patients with prior left atrial appendage occlusion device","authors":"Jakrin Kewcharoen, Kuldeep Shah, Rahul Bhardwaj, Tahmeed Contractor, Davendra Ramsingh, Mohit K. Turagam, Ravi Mandapati, Dhanunjaya Lakkireddy, Jalaj Garg","doi":"10.1007/s10840-024-01914-8","DOIUrl":"https://doi.org/10.1007/s10840-024-01914-8","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>The safety and efficacy of CA for AF and left-sided atrial arrhythmias (AA) in patients with left atrial appendage occlusion (LAAO) devices are lacking.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>This is a single-center retrospective registry that included all patients with prior LAAO who underwent catheter ablation for AF or left-sided atrial arrhythmia from January 2020–January 2023. The primary outcomes were procedure-related complications, device-related complications, AA recurrence, and stroke.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>A total of 30 patients with prior LAAO were included in the analysis (mean age 75.1 ± 7.1 years old, 50% male, mean CHA<sub>2</sub>DS<sub>2</sub>-VASc score 4 ± 1.6, 46.7% paroxysmal AF, 73.3% had prior AF ablation, mean time to ablation 475 ± 365 days). 93.3% (<i>n</i> = 28) and 6.6% (<i>n</i> = 2) patients had ablation for AF (46.7% paroxysmal, 36.7% persistent, 10% long-standing persistent) and left-sided atrial tachycardia, respectively. 16.7% (<i>n</i> = 5) patients underwent ablation along the left atrial appendage ostium, and 3.3% (<i>n</i> = 1) underwent Vein of Marshall alcohol ablation. There were 3 (10%) peri-procedural complications (1 access hematoma and two pericardial effusions requiring intervention—none related to left atrial appendage ostium or alcohol ablation). During the mean follow-up of 440 ± 379 days, 40% (<i>n</i> = 12) patients had AA recurrence (91.6% AF, 8.3% atrial tachycardia), of which five patients needed repeat ablation, and two patients were readmitted for heart failure. There was no stroke or any device-related complications, including new peri-device leaks or device-related thrombosis in patients who had follow-up imaging studies (<i>n</i> = 11, 36.7%).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Catheter ablation for AF (including VoM alcohol ablation) in patients with prior LAAO devices is feasible and safe with favorable outcomes.</p><h3 data-test=\"abstract-sub-heading\">Graphical Abstract</h3>\u0000","PeriodicalId":16202,"journal":{"name":"Journal of Interventional Cardiac Electrophysiology","volume":"35 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142208340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inadvertent 3830 pacing lead placement in the left ventricle through an atrial septal defect in a congenitally corrected transposition of great arteries patient: a multidisciplinary approach 先天性大动脉转位矫正患者无意中通过房间隔缺损将 3830 起搏导线置入左心室:一种多学科方法
IF 1.8 4区 医学
Journal of Interventional Cardiac Electrophysiology Pub Date : 2024-09-10 DOI: 10.1007/s10840-024-01919-3
Federico Migliore, Raimondo Pittorru, Manuel De Lazzari, Nicola Pradegan, Francesco Zanon, Lina Marcantoni, Fabio Scattolin, Gino Gerosa, Giuseppe Tarantini
{"title":"Inadvertent 3830 pacing lead placement in the left ventricle through an atrial septal defect in a congenitally corrected transposition of great arteries patient: a multidisciplinary approach","authors":"Federico Migliore, Raimondo Pittorru, Manuel De Lazzari, Nicola Pradegan, Francesco Zanon, Lina Marcantoni, Fabio Scattolin, Gino Gerosa, Giuseppe Tarantini","doi":"10.1007/s10840-024-01919-3","DOIUrl":"https://doi.org/10.1007/s10840-024-01919-3","url":null,"abstract":"","PeriodicalId":16202,"journal":{"name":"Journal of Interventional Cardiac Electrophysiology","volume":"2 1","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142208339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety, efficacy, and quality of life outcomes of pulsed field ablation in Japanese patients with atrial fibrillation: results from the PULSED AF trial. 日本心房颤动患者脉冲场消融术的安全性、疗效和生活质量:PULSED 心房颤动试验的结果。
IF 2.1 4区 医学
Journal of Interventional Cardiac Electrophysiology Pub Date : 2024-09-07 DOI: 10.1007/s10840-024-01912-w
Teiichi Yamane, Tetsuo Sasano, Hirofumi Tomita, Daisetsu Aoyama, Shinsuke Miyazaki, Masateru Takigawa, Masaomi Kimura, Taihei Itoh, Seigo Yamashita, Jada M Selma, Jeffrey Cerkvenik, Atul Verma, Hiroshi Tada
{"title":"Safety, efficacy, and quality of life outcomes of pulsed field ablation in Japanese patients with atrial fibrillation: results from the PULSED AF trial.","authors":"Teiichi Yamane, Tetsuo Sasano, Hirofumi Tomita, Daisetsu Aoyama, Shinsuke Miyazaki, Masateru Takigawa, Masaomi Kimura, Taihei Itoh, Seigo Yamashita, Jada M Selma, Jeffrey Cerkvenik, Atul Verma, Hiroshi Tada","doi":"10.1007/s10840-024-01912-w","DOIUrl":"https://doi.org/10.1007/s10840-024-01912-w","url":null,"abstract":"<p><strong>Background: </strong>Pulsed field ablation (PFA), a novel treatment for atrial fibrillation (AF), has yet to be evaluated in a Japanese cohort.</p><p><strong>Methods: </strong>In this sub-analysis of the PULSED AF trial, 12-month outcomes of paroxysmal AF (PAF) and persistent AF (PsAF) patients treated with PFA in four Japan centers were assessed. After a 90-day blanking period, primary efficacy was determined via freedom from a composite endpoint of acute procedural failure, arrhythmia recurrence, or antiarrhythmic drug escalation over 1 year. Patient improvement was evaluated via two quality of life (QoL) surveys (AFEQT and EQ-5D) at baseline and 12 months.</p><p><strong>Results: </strong>The analysis included 32 patients, 16 PAF and 16 PsAF, with PAF patients averaging 61.1 ± 10.6 years and PsAF patients averaging 62.8 ± 11.5 years of age. Females made up 31% of PAF and 25% of PsAF cohorts. Acute pulmonary vein isolation was achieved in 100% of both cohorts. The primary efficacy success rate at 12 months was 75.0% for PAF and 56.3% for PsAF patients. No primary safety events occurred. The mean AFEQT score significantly increased for both PAF (25.9 points, p < 0.0001) and PsAF (13.2 points, p = 0.0002) patients, while the EQ-5D-5L score improved significantly for PAF (0.12 points, p = 0.048) patients but not for PsAF (0.04 points, p = 0.08) patients.</p><p><strong>Conclusions: </strong>Similar to outcomes in the global cohort, ablation with the PulseSelect™ PFA catheter was efficient, effective, and safe in a Japanese population, resulting in improved QoL for PAF and PsAF patients.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov Identifier: NCT04198701.</p>","PeriodicalId":16202,"journal":{"name":"Journal of Interventional Cardiac Electrophysiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Omnipolar mapping for increased precision in atrial fibrillation ablation. 用于提高心房颤动消融精确度的全极绘图。
IF 2.1 4区 医学
Journal of Interventional Cardiac Electrophysiology Pub Date : 2024-09-05 DOI: 10.1007/s10840-024-01917-5
Shivaraj Patil, Abhishek Deshmukh, Christopher V DeSimone
{"title":"Omnipolar mapping for increased precision in atrial fibrillation ablation.","authors":"Shivaraj Patil, Abhishek Deshmukh, Christopher V DeSimone","doi":"10.1007/s10840-024-01917-5","DOIUrl":"https://doi.org/10.1007/s10840-024-01917-5","url":null,"abstract":"","PeriodicalId":16202,"journal":{"name":"Journal of Interventional Cardiac Electrophysiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catheter ablation alone versus catheter ablation with combined percutaneous left atrial appendage closure for atrial fibrillation: a systematic review and meta-analysis. 单纯导管消融与导管消融联合经皮左心房阑尾封堵术治疗心房颤动:系统综述与荟萃分析。
IF 2.1 4区 医学
Journal of Interventional Cardiac Electrophysiology Pub Date : 2024-09-04 DOI: 10.1007/s10840-024-01915-7
Joey Junarta, Muhammad U Siddiqui, Ehab Abaza, Peter Zhang, Aarash Roshandel, Chirag R Barbhaiya, Lior Jankelson, David S Park, Douglas Holmes, Larry A Chinitz, Anthony Aizer
{"title":"Catheter ablation alone versus catheter ablation with combined percutaneous left atrial appendage closure for atrial fibrillation: a systematic review and meta-analysis.","authors":"Joey Junarta, Muhammad U Siddiqui, Ehab Abaza, Peter Zhang, Aarash Roshandel, Chirag R Barbhaiya, Lior Jankelson, David S Park, Douglas Holmes, Larry A Chinitz, Anthony Aizer","doi":"10.1007/s10840-024-01915-7","DOIUrl":"https://doi.org/10.1007/s10840-024-01915-7","url":null,"abstract":"<p><strong>Background: </strong>Combined catheter ablation (CA) with percutaneous left atrial appendage closure (LAAC) may produce comprehensive treatment for atrial fibrillation (AF) whereby rhythm control is achieved and stroke risk is reduced without the need for chronic oral anticoagulation. However, the efficacy and safety of this strategy is still controversial.</p><p><strong>Methods: </strong>This meta-analysis was reported according to the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. Medline, Scopus, and Cochrane Central Register of Controlled Trials were systematically searched to identify relevant studies. The risk of bias was assessed using the Modified Newcastle-Ottawa scale and Cochrane risk of bias tool. Eligible studies reported outcomes in patients with AF who underwent combined CA and LAAC vs CA alone. Studies performing CA without pulmonary vein isolation were excluded.</p><p><strong>Results: </strong>Eight studies comprising 1878 patients were included (2 RCT, 6 observational). When comparing combined CA and LAAC vs CA alone, pooled results showed no difference in arrhythmia recurrence (risk ratio (RR) 1.04; 95% confidence interval (CI) 0.82-1.33), stroke or systemic embolism (RR 0.78; 95% CI 0.27-2.22), or major periprocedural complications (RR 1.28; 95% CI 0.28-5.89). Total procedure time was shorter with CA alone (mean difference 48.45 min; 95% CI 23.06-74.62).</p><p><strong>Conclusion: </strong>Combined CA with LAAC for AF is associated with similar rates of arrhythmia-free survival, stroke, and major periprocedural complications when compared to CA alone. A combined strategy may be as safe and efficacious for patients at moderate to high risk for bleeding events to negate the need for chronic oral anticoagulation.</p>","PeriodicalId":16202,"journal":{"name":"Journal of Interventional Cardiac Electrophysiology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bangungut, risk stratification and late potentials in Brugada syndrome. Brugada综合征的Bangungut、风险分层和晚期电位。
IF 2.1 4区 医学
Journal of Interventional Cardiac Electrophysiology Pub Date : 2024-09-01 Epub Date: 2024-02-20 DOI: 10.1007/s10840-024-01774-2
Manlio F Márquez, Margarita Dorantes
{"title":"Bangungut, risk stratification and late potentials in Brugada syndrome.","authors":"Manlio F Márquez, Margarita Dorantes","doi":"10.1007/s10840-024-01774-2","DOIUrl":"10.1007/s10840-024-01774-2","url":null,"abstract":"","PeriodicalId":16202,"journal":{"name":"Journal of Interventional Cardiac Electrophysiology","volume":" ","pages":"1287-1288"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139905813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking appropriate blanking period after atrial fibrillation ablation. 重新思考心房颤动消融术后的适当空白期。
IF 2.1 4区 医学
Journal of Interventional Cardiac Electrophysiology Pub Date : 2024-09-01 Epub Date: 2024-02-16 DOI: 10.1007/s10840-024-01754-6
Naoaki Onishi, Akihira Suenaga, Akinori Yoshida, Takayasu Kobayashi, Shokan Kyo, Maki Oi, Nobuya Higashitani, Fumiko Nakazeki, Naofumi Oyamada, Toshikazu Jinnai, Kazuaki Kaitani
{"title":"Rethinking appropriate blanking period after atrial fibrillation ablation.","authors":"Naoaki Onishi, Akihira Suenaga, Akinori Yoshida, Takayasu Kobayashi, Shokan Kyo, Maki Oi, Nobuya Higashitani, Fumiko Nakazeki, Naofumi Oyamada, Toshikazu Jinnai, Kazuaki Kaitani","doi":"10.1007/s10840-024-01754-6","DOIUrl":"10.1007/s10840-024-01754-6","url":null,"abstract":"<p><strong>Background: </strong>Early recurrence (ER) within a 90-day blanking period (BP) in catheter ablation (CA) for atrial fibrillation (AF) is a risk factor for late recurrence (LR) after 90 days postoperatively. However, few reports have examined them in the second CA and compared them to the first CA. Moreover, in recent years, there have been reports suggesting that BP should be reduced from 90 to 30 days. Therefore, the association between ER and LR in the first and the second CA was examined, and the validity of a 30-day BP was evaluated.</p><p><strong>Methods: </strong>A total of 511 consecutive patients undergoing the first CA and 116 of these patients undergoing the second CA for AF at a single institution from November 2016 to December 2020 were analyzed retrospectively.</p><p><strong>Results: </strong>When ER within a 90-day BP was divided into 0-30 days and 31-90 days according to the timing of the last ER episode, the hazard ratios on LR of them relative to no ER were 2.7 {95% confidence interval (CI) 1.7-4.2} and 9.7 (95% CI 6.6-14.3), respectively, for the first CA and 15.3 (95% CI 4.7-50.1) and 44.1 (95% CI 14.0-139.4), respectively, for the second CA.</p><p><strong>Conclusions: </strong>ER was strongly associated with LR, especially in patients with the last episode of ER more than 30 days after CA. This was pronounced in cases after the second CA, when PVI appeared to be completed. With the current improvement in PVI durability, BP may be acceptable for 30 days.</p>","PeriodicalId":16202,"journal":{"name":"Journal of Interventional Cardiac Electrophysiology","volume":" ","pages":"1427-1436"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139741255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Device infection in patients undergoing pacemaker or defibrillator surgery: risk stratification using the PADIT score. 接受起搏器或除颤器手术患者的设备感染:使用 PADIT 评分进行风险分层。
IF 2.1 4区 医学
Journal of Interventional Cardiac Electrophysiology Pub Date : 2024-09-01 Epub Date: 2024-01-30 DOI: 10.1007/s10840-024-01759-1
John de Heide, Marisa van der Graaf, Marijn J Holl, Mark G Hoogendijk, Rohit E Bhagwandien, Sip A Wijchers, Dominic A M J Theuns, Tamas Szili-Torok, Felix Zijlstra, Mattie J Lenzen, Sing-Chien Yap
{"title":"Device infection in patients undergoing pacemaker or defibrillator surgery: risk stratification using the PADIT score.","authors":"John de Heide, Marisa van der Graaf, Marijn J Holl, Mark G Hoogendijk, Rohit E Bhagwandien, Sip A Wijchers, Dominic A M J Theuns, Tamas Szili-Torok, Felix Zijlstra, Mattie J Lenzen, Sing-Chien Yap","doi":"10.1007/s10840-024-01759-1","DOIUrl":"10.1007/s10840-024-01759-1","url":null,"abstract":"<p><strong>Background: </strong>The use of an antibacterial envelope is cost-effective for patients at high risk of developing cardiac implantable electronic device (CIED) infection. The identification of these high-risk patients may be facilitated using a clinical risk score. The aim of the current study is to evaluate the PADIT score for identifying high-risk patients in patients undergoing a CIED procedure in a tertiary academic center.</p><p><strong>Methods: </strong>This was a retrospective single-center study of consecutive patients undergoing a CIED procedure between January 2016 and November 2021. Patients who received an antibacterial envelope were excluded from this study. The primary endpoint was hospitalization for a CIED infection in the first year after the procedure.</p><p><strong>Results: </strong>A total of 2333 CIED procedures were performed in the study period (mean age 61.6 ± 16.3 years, male sex 64.5%, previous CIED infection 1.7%, immunocompromised 5.4%). The median PADIT score was 4 (interquartile range, 2-6). CIED infection occurred in 10 patients (0.43%). The PADIT score had good discrimination in predicting major CIED infection (C-statistic 0.70; 95% confidence interval [CI] 0.54 to 0.86, P = 0.03). Using an optimal PADIT score cut-off value of 7, the risk of CIED infection was higher in the patients with a PADIT score of ≥ 7 in comparison to those with a lower PADIT score (1.23% vs. 0.26%, P = 0.02; odds ratio 4.8, 95% CI 1.4 to 16.6, P = 0.01).</p><p><strong>Conclusions: </strong>The PADIT score is a clinically useful score for identifying patients at high risk of developing CIED infection. The use of an antibacterial envelope in these high-risk patients may be cost-effective.</p>","PeriodicalId":16202,"journal":{"name":"Journal of Interventional Cardiac Electrophysiology","volume":" ","pages":"1419-1426"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11379746/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139576011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of high-power short-duration ablation for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. 高功率短时消融术治疗心房颤动的疗效和安全性:随机对照试验的系统回顾和荟萃分析。
IF 2.1 4区 医学
Journal of Interventional Cardiac Electrophysiology Pub Date : 2024-09-01 Epub Date: 2024-03-09 DOI: 10.1007/s10840-024-01782-2
Ahmed Mazen Amin, Ramy Ghaly, Ahmed A Ibrahim, Mohamed Ahmed Ali, Omar Almaadawy, Amr Elzahaby, Mohamed Abuelazm, Basel Abdelazeem, Muhammad Bilal Munir
{"title":"Efficacy and safety of high-power short-duration ablation for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.","authors":"Ahmed Mazen Amin, Ramy Ghaly, Ahmed A Ibrahim, Mohamed Ahmed Ali, Omar Almaadawy, Amr Elzahaby, Mohamed Abuelazm, Basel Abdelazeem, Muhammad Bilal Munir","doi":"10.1007/s10840-024-01782-2","DOIUrl":"10.1007/s10840-024-01782-2","url":null,"abstract":"<p><strong>Background: </strong>High-power short-duration (HPSD) ablation has emerged as an alternative to conventional standard-power long-duration (SPLD) ablation. We aim to assess the efficacy and safety of HPSD versus SPLD for atrial fibrillation (AF) ablation.</p><p><strong>Methods: </strong>A systematic review and meta-analysis of randomized controlled trials (RCTs) retrieved from PubMed, WOS, SCOPUS, EMBASE, and CENTRAL were performed through August 2023. We used RevMan V. 5.4 to pool dichotomous data using risk ratio (RR) and continuous data using mean difference (MD) with a 95% confidence interval (CI).</p><p><strong>Prospero id: </strong>CRD42023471797.</p><p><strong>Results: </strong>We included six RCTs with a total of 694 patients. HPSD was significantly associated with a decreased total procedure time (MD: -22.88 with 95% CI [-36.13, -9.63], P = 0.0007), pulmonary vein isolation (PVI) time (MD: -19.73 with 95% CI [-23.93, -15.53], P < 0.00001), radiofrequency time (MD: -10.53 with 95% CI [-12.87, -8.19], P < 0.00001). However, there was no significant difference between HPSD and SPLD ablation with respect to the fluoroscopy time (MD: -0.69 with 95% CI [-2.00, 0.62], P = 0.30), the incidence of esophageal lesions (RR: 1.15 with 95% CI [0.43, 3.07], P = 0.77), and the incidence of first pass isolation (RR: 0.98 with 95% CI [0.88, 1.08], P = 0.65).</p><p><strong>Conclusion: </strong>HPSD ablation was significantly associated with decreased total procedure time, PVI time, and radiofrequency time compared with SPLD ablation. On the contrary, SPLD ablation was significantly associated with low maximum temperature.</p>","PeriodicalId":16202,"journal":{"name":"Journal of Interventional Cardiac Electrophysiology","volume":" ","pages":"1445-1461"},"PeriodicalIF":2.1,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11379757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140068389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信